Does OCTREOTIDE Cause Second primary malignancy? 496 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 496 reports of Second primary malignancy have been filed in association with OCTREOTIDE (Octreotide Acetate). This represents 2.1% of all adverse event reports for OCTREOTIDE.
496
Reports of Second primary malignancy with OCTREOTIDE
2.1%
of all OCTREOTIDE reports
125
Deaths
282
Hospitalizations
How Dangerous Is Second primary malignancy From OCTREOTIDE?
Of the 496 reports, 125 (25.2%) resulted in death, 282 (56.9%) required hospitalization, and 11 (2.2%) were considered life-threatening.
Is Second primary malignancy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OCTREOTIDE. However, 496 reports have been filed with the FAERS database.
What Other Side Effects Does OCTREOTIDE Cause?
Death (3,801)
Diarrhoea (3,621)
Fatigue (2,933)
Blood pressure increased (2,799)
Needle issue (2,740)
Malaise (2,737)
Pain (2,366)
Blood pressure systolic increased (2,340)
Malignant neoplasm progression (2,306)
Nausea (2,294)
What Other Drugs Cause Second primary malignancy?
CYCLOPHOSPHAMIDE (1,247)
DOXORUBICIN (1,151)
VINCRISTINE (908)
IMATINIB (763)
PALBOCICLIB (658)
RITUXIMAB (646)
RUXOLITINIB (611)
ETOPOSIDE (573)
PREDNISONE (517)
METHOTREXATE (414)
Which OCTREOTIDE Alternatives Have Lower Second primary malignancy Risk?
OCTREOTIDE vs OCTREOTIDE\OCTREOTIDE
OCTREOTIDE vs ODEVIXIBAT
OCTREOTIDE vs OFATUMUMAB
OCTREOTIDE vs OFLOXACIN
OCTREOTIDE vs OLANZAPINE